NOTICE OF ALLOWANCE - ISSUED
issued
on 27 Aug 2024
Last Applicant/ Owned by
680 Folsom Street, 5th Floor
San Francisco
CA
94107
Serial Number
98197383 filed on 26th Sep 2023
Registration Number
N/A
Correspondent Address
Jordan A. LaVine
Filing Basis
1. intent to use
2. intent to use current
Disclaimer
NO DATA
MAPKIT
Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare viewing of a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral Read More
Classification Information
Class [042]
Computer & Software Services & Scientific Services
Platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare viewing of a database with information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (PaaS) featuring computer software platforms that allows organizations and stakeholders in healthcare the ability to model patient journeys, pathways, and care programs, all of the foregoing excluding psychedelic medicines and therapies; computer services, namely, database development services, namely, configuration and customization of databases containing information, data, statistics, insights, metrics, profiles, analytics and intelligence healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, lab data, care demographics, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; platform-as-a-service (paas) featuring computer software platforms that allow the viewing of market access insights to the life sciences industry, provide business solutions that unify pharmaceutical sales, operations, and marketing data, and provide data intelligence that aids with effective targeting, messaging, and initiatives driving sales performance, all of the foregoing excluding psychedelic medicines and therapies; Design, development and implementation of computer software for the healthcare and life sciences industry, namely, the design and development of cloud-based and application-based software for monitoring, marketing, and delivering products in the healthcare and life sciences industry, all of the foregoing excluding psychedelic medicines and therapies; Consulting services in the fields of selection, implementation and use of computer hardware and software systems for others in the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies; Business technology software consultation services in the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies; Software development and product development consulting in the field of the health care and life science industries, all of the foregoing excluding psychedelic medicines and therapies
First Use Date in General
N/A
First Use Date in Commerce
N/A
Class [035]
Advertising, Business & Retail Services
Business data collection and analysis services in the field of healthcare, namely, aggregating, organizing and compiling of information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; business consulting and analysis services regarding information, data, statistics, insights, metrics, profiles, analytics and intelligence on healthcare industry demographics, practitioner demographics, patient demographics, patient therapies and treatments, prescriptions, patient flows and referral pathways, disease demographics, care demographics, lab data, clinical study and trial demographics, healthcare behaviors, costs, and outcomes, payer data, and scientific publications, all of the foregoing excluding psychedelic medicines and therapies; Providing business information in the field of the healthcare and life sciences industries, all of the foregoing excluding psychedelic medicines and therapies; Business consulting services to businesses in the healthcare and life sciences industries, all of the foregoing excluding psychedelic medicines and therapies
First Use Date in General
N/A
First Use Date in Commerce
N/A
Mark Details
Serial Number
No 98197383
Mark Type
No Service Mark
Attorney Docket Number
No
44D Filed
No
44D Current
No
44E filed
No
44E Current
No
66A Filed
No
66A Current
No
Current Basis
No
No Basis
No
Legal History
| Status Date | Action Taken |
|---|---|
| 27th Aug 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| 02th Jul 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
| 02th Jul 2024 | PUBLISHED FOR OPPOSITION |
| 12th Jun 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| 24th May 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| 22nd May 2024 | EXAMINER'S AMENDMENT ENTERED |
| 22nd May 2024 | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED |
| 22nd May 2024 | EXAMINERS AMENDMENT E-MAILED |
| 22nd May 2024 | EXAMINERS AMENDMENT -WRITTEN |
| 21st May 2024 | EXAMINER'S AMENDMENT ENTERED |